ANCA-associated scleritis: impact of ANCA on presentation, response to therapy and outcome.
Perray L, Nguyen Y, Clavel Refregiers G, Chazal T, Héron E, Pouchelon C, Dunogué B, Costedoat-Chalumeau N, Murarasu A, Régent A, Puéchal X, Thoreau B, Lifermann F, Graveleau J, Hié M, Froissart A, Baudet A, Deroux A, Lavigne C, Puigrenier S, Mesbah R, Moulinet T, Vasco C, Revuz S, Pugnet G, Rieu V, Combes A, Brézin A, Terrier B.
Perray L, et al.
Rheumatology (Oxford). 2024 Feb 1;63(2):329-337. doi: 10.1093/rheumatology/kead252.
Rheumatology (Oxford). 2024.
PMID: 37233203